- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Elevation Oncology Stock (NASDAQ:ELEV), Quotes and News Summary
Elevation Oncology Stock (NASDAQ: ELEV)
| Day Range1.12 - 1.2 | 52 Wk Range0.98 - 6.87 | Open / Close1.18 / 1.13 | Float / Outstanding14.9M / 23.3M |
| Vol / Avg.65K / 84.8K | Mkt Cap26.3M | P/E0.17 | 50d Avg. Price1.22 |
| Div / Yield- | Payout Ratio- | Total Float14.9M | EPS-0.86 |
Earnings
see more| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-11-11 | ||||||
| REV | |||||||
| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.860 | ||||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Elevation Oncology Questions & Answers
You can purchase shares of Elevation Oncology (NASDAQ: ELEV) through any online brokerage.
Other companies in Elevation Oncology’s space includes: Vincerx Pharma (NASDAQ:VINC), Aeglea BioTherapeutics (NASDAQ:AGLE), Celyad Oncology (NASDAQ:CYAD), Geovax Labs (NASDAQ:GOVX) and GlycoMimetics (NASDAQ:GLYC).
The latest price target for Elevation Oncology (NASDAQ: ELEV) was reported by HC Wainwright & Co. on Monday, September 19, 2022. The analyst firm set a price target for 7.50 expecting ELEV to rise to within 12 months (a possible 563.72% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Elevation Oncology (NASDAQ: ELEV) is $1.13 last updated September 30, 2022, 8:00 PM UTC.
There are no upcoming dividends for Elevation Oncology.
Elevation Oncology’s Q3 earnings are confirmed for Friday, November 11, 2022.
There is no upcoming split for Elevation Oncology.
Elevation Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.